Home | Business News | Browse by Publication | M | Medical Letter on the CDC & FDA

New heart failure research from M.Z. Hoque and co-researchers described.

Publication: Medical Letter on the CDC & FDA
Publication Date: 25-OCT-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
"Conivaptan, the first vasopressin receptor antagonist approved by the FDA, is available for the treatment of hyponatremia in euvolemic and hypervolemic patients," scientists in the United States report (see also Heart Failure).

"The renin-angiotensin-aldosterone system is activated in heart failure (HF) causing clinical worsening. Arginine vasopressin levels are also...



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.